NM_006946.4:c.4418T>C
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 1P and 5B. PP3BP6BS1
The NM_006946.4(SPTBN2):c.4418T>C(p.Leu1473Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000489 in 1,614,100 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_006946.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive spinocerebellar ataxia 14Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Orphanet
- spinocerebellar ataxia type 5Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Illumina, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006946.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SPTBN2 | NM_006946.4 | MANE Select | c.4418T>C | p.Leu1473Ser | missense | Exon 22 of 38 | NP_008877.2 | ||
| SPTBN2 | NM_001411025.1 | c.4439T>C | p.Leu1480Ser | missense | Exon 20 of 36 | NP_001397954.1 | |||
| SPTBN2 | NM_001437541.1 | c.4418T>C | p.Leu1473Ser | missense | Exon 21 of 37 | NP_001424470.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SPTBN2 | ENST00000533211.6 | TSL:5 MANE Select | c.4418T>C | p.Leu1473Ser | missense | Exon 22 of 38 | ENSP00000432568.1 | ||
| SPTBN2 | ENST00000309996.7 | TSL:1 | c.4418T>C | p.Leu1473Ser | missense | Exon 21 of 37 | ENSP00000311489.2 | ||
| SPTBN2 | ENST00000617502.5 | TSL:5 | c.4439T>C | p.Leu1480Ser | missense | Exon 20 of 36 | ENSP00000482000.2 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152234Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000597 AC: 15AN: 251272 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000274 AC: 40AN: 1461748Hom.: 0 Cov.: 32 AF XY: 0.0000206 AC XY: 15AN XY: 727188 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000256 AC: 39AN: 152352Hom.: 0 Cov.: 32 AF XY: 0.000268 AC XY: 20AN XY: 74494 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.4418T>C (p.L1473S) alteration is located in exon 21 (coding exon 20) of the SPTBN2 gene. This alteration results from a T to C substitution at nucleotide position 4418, causing the leucine (L) at amino acid position 1473 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
not specified Benign:1
not provided Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at